Teva Pharmaceutical Industries Ltd (TEVJF) Change in Acquisitions & Divestments (2009 - 2025)

Teva Pharmaceutical Industries (TEVJF) has 16 years of Change in Acquisitions & Divestments data on file, last reported at $42.0 million in Q4 2025.

• Quarterly Change in Acquisitions & Divestments changed N/A year-over-year to $42.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $82.0 million (up 105.0% YoY) and the FY2025 annual result came in at $42.0 million, up 5.0% from the prior year.
• Change in Acquisitions & Divestments advanced to $42.0 million in Q4 2025, from $40.0 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $107.0 million in Q2 2021 to a low of $1.0 million in Q3 2022.
• A 4-year average of $36.9 million and a median of $40.0 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
• Annual changes were most pronounced in 2021 — Change in Acquisitions & Divestments jumped 3466.67% — and 2022, when it tumbled 97.2%.
• Tracing TEVJF's Change in Acquisitions & Divestments over 4 years: stood at $19.0 million in 2021, then tumbled by 94.74% to $1.0 million in 2022, then soared by 3900.0% to $40.0 million in 2024, then gained by 5.0% to $42.0 million in 2025.
• The last three Change in Acquisitions & Divestments figures came in at $42.0 million (Q4 2025), $40.0 million (Q3 2024), and $1.0 million (Q3 2022), per Business Quant data.